This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is not an aspect of making AT and AAC an effective tool? a. An evaluation ... (Read 16 times)

KWilfred

  • Hero Member
  • *****
  • Posts: 570
Which of the following is not an aspect of making AT and AAC an effective tool?
 
  a. An evaluation of the student's communication skills and needs must be conducted.
  b. Training and technical assistance for the device must be secured.
  c. A regularly-abled person must test the device.
  d. Procedures for maintaining and troubleshooting the device must be established.

Question 2

Children who cannot see, or who have impaired vision, tend to struggle with:
 
  a. Spatial Information
  b. Names
  c. Temporal Aspects
  d. Categorization



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Melissahxx

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

c

Answer to Question 2

a




KWilfred

  • Member
  • Posts: 570
Reply 2 on: Jun 20, 2018
:D TYSM


bitingbit

  • Member
  • Posts: 323
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

Cucumber slices relieve headaches by tightening blood vessels, reducing blood flow to the area, and relieving pressure.

Did you know?

Atropine was named after the Greek goddess Atropos, the oldest and ugliest of the three sisters known as the Fates, who controlled the destiny of men.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library